Genomic Solutions Expects Revenue Growth from Proteomics | GenomeWeb

NEW YORK, Sept 21 – Genomics and proteomics company Genomic Solutions (Nasdaq: GNSL) said Thursday it expects sales of its proteomics tools and services to comprise a greater proportion of revenues in 2000 than in 1999.

“Proteomics is definitely growing,” said Christine Ethier, vice president of the proteomics business unit at Genomic Solutions. “Proteomics accounted for 15 percent of sales last year and this year it will account for 20-25 percent of revenues.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.